DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 03 · Volume 54 · May 2021 DOI: 10.1055/s-011-50840

Original Paper

101
Petermann, Markus; Kronenberg, Golo; Mosienko, Valentina; Bader, Michael; Alenina, Natalia; Hellweg, Rainer; Klempin, Friederike: Alterations in BDNF Protein Concentrations in the Hippocampus do not Explain the Pro-Neurogenic Effect of Citalopram on Adult Neurogenesis
106
Kato, Hideo; Koizumi, Teruki; Takeuchi, Hiroyoshi; Tani, Hideaki; Mimura, Masaru; Uchida, Hiroyuki: Effects of Discontinuation of Drugs Used for Augmentation Therapy on Treatment Outcomes in Depression: A Systematic Review and Meta-analysis
Supplementary Material
117
Fekete, Stefanie; Scherf-Clavel, Maike; Gerlach, Manfred; Romanos, Marcel; Kittel-Schneider, Sarah; Unterecker, Stefan; Egberts, Karin: Dose-Corrected Serum Concentrations and Metabolite to Parent Compound Ratios of Venlafaxine and Risperidone from Childhood to Old Age
Supplementary Material
126
Bohlken, Jens; Riedel-Heller, Steffi; Bauer, Michael; Kostev, Karel: Bipolar Disorder and Outcomes of Monotherapy with Lithium, Valproate, Quetiapine, Olanzapine, Venlafaxine, and Citalopram
131
Hao, Yong; Tong, Yingpeng; Guo, Yanhong; Lang, Xiaoe; Huang, Xinxin; Xie, Xiaoxian; Guan, Yangtai; Li, Zezhi: Metformin Attenuates the Metabolic Disturbance and Depression-like Behaviors Induced by Corticosterone and Mediates the Glucose Metabolism Pathway
Supplementary Material

Letter to the Editor

142
Bonnet, Udo; Juckel, Georg; Scherbaum, Norbert; Schaefer, Martin; Kis, Bernhard; Cohen, Simon; Kuhn, Jens: Are Persons Treated with Antidepressants and/or Antipsychotics Possibly Better Protected against Severe COVID 19?